Anti-TGF-beta antibodies and their use

MYPI2025007246A0Undetermined Publication Date: 2018-07-20SANOFI SA(FR)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025007246
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-01-19
Filing Date
2018-01-19
Publication Date
2018-07-20
Patent Text Reader

Abstract

The invention provides an improved pan-TGF-β antibody for treatment of conditions that are mediated by TGF-β, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
Need to check novelty before this filing date? Find Prior Art